Page last updated: 2024-08-26

arsenic and tamoxifen

arsenic has been researched along with tamoxifen in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MH; Flamm Honig, S; Hirschfeld, S; Ibrahim, A; Johnson, JR; O'Leary, JJ; Pazdur, R; White, RM; Williams, GA1
Diwan, BA; Liu, J; Powell, DA; Waalkes, MP; Ward, JM1
Diwan, BA; Liu, J; Waalkes, MP; Ward, JM1
Diwan, BA; Liu, J; Waalkes, MP1
Fan, Q; Lu, SH; Ma, Z; Wang, F; Wang, L; Wang, R; Wu, X; Yang, J; Zhang, W1
Flomenberg, N; Goldberg, A; Howell, A; Ko, YH; Lin, Z; Lisanti, MP; Martinez-Outschoorn, UE; Pavlides, S; Pestell, RG; Sotgia, F; Wang, C1
Fan, QX; Wang, F; Wang, LX; Wang, R; Wu, XA; Xu, DF; Zhang, WJ1
Adachi, K; Honma, Y; Kawakami, K; Miyake, T; Suzumiya, J; Takahashi, T1

Other Studies

8 other study(ies) available for arsenic and tamoxifen

ArticleYear
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
    The oncologist, 2001, Volume: 6, Issue:1

    Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Bexarotene; Breast Neoplasms; Drug Approval; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, T-Cell, Cutaneous; Nitriles; Oxides; Paclitaxel; Tamoxifen; Tetrahydronaphthalenes; Triazoles; United States; United States Food and Drug Administration

2001
Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment.
    Cancer research, 2006, Feb-01, Volume: 66, Issue:3

    Topics: Animals; Arsenic; Body Weight; Diethylstilbestrol; Drinking; Drug Synergism; Estrogen Receptor alpha; Female; Gene Expression; Genital Neoplasms, Female; Kidney Neoplasms; Maternal-Fetal Exchange; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Tamoxifen; Urinary Bladder Neoplasms; Uterus

2006
Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.
    Toxicology and applied pharmacology, 2006, Sep-15, Volume: 215, Issue:3

    Topics: Animals; Arsenic; Diethylstilbestrol; Drug Synergism; Estrogen Receptor alpha; Estrogens, Non-Steroidal; Female; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Pregnancy; Prenatal Exposure Delayed Effects; Selective Estrogen Receptor Modulators; Tamoxifen; Urinary Bladder Neoplasms

2006
Transplacental arsenic carcinogenesis in mice.
    Toxicology and applied pharmacology, 2007, Aug-01, Volume: 222, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Arsenic; Arsenicals; Carcinogens; Carcinoma, Transitional Cell; Data Interpretation, Statistical; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Female; Gene Expression Regulation, Neoplastic; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Signal Transduction; Skin Neoplasms; Tamoxifen; Tetradecanoylphorbol Acetate; Urinary Bladder Neoplasms

2007
Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.
    Oncology reports, 2011, Volume: 26, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oxides; Tamoxifen; Transcription, Genetic; Tumor Burden; Xenograft Model Antitumor Assays

2011
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.
    Cancer biology & therapy, 2011, Nov-15, Volume: 12, Issue:10

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Coculture Techniques; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fibroblasts; Fulvestrant; Humans; Hypoglycemic Agents; Intracellular Signaling Peptides and Proteins; Ketone Bodies; Lactic Acid; Metformin; Mitochondria; Oxides; Phosphoric Monoester Hydrolases; Poly(ADP-ribose) Polymerase Inhibitors; Tamoxifen; Tumor Microenvironment

2011
[Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:9

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oxides; RNA, Messenger; Tamoxifen; Tumor Burden; Xenograft Model Antitumor Assays

2012
Tamoxifen enhances the differentiation-inducing and growth-inhibitory effects of all-trans retinoic acid in acute promyelocytic leukemia cells.
    International journal of oncology, 2016, Volume: 48, Issue:3

    Topics: Animals; Anthracyclines; Antineoplastic Agents, Hormonal; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; CD11b Antigen; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, Inbred BALB C; Middle Aged; Oxides; Tamoxifen; Tretinoin

2016